about
CCDB: a curated database of genes involved in cervix cancerQuantifying mRNA and microRNA with qPCR in cervical carcinogenesis: a validation of reference genes to ensure accurate dataAICAR inhibits proliferation and induced S-phase arrest, and promotes apoptosis in CaSki cells.Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.A 7 gene expression score predicts for radiation response in cancer cervixIdentification and validation of genes involved in cervical tumourigenesis.Tumor cell-derived MMP3 orchestrates Rac1b and tissue alterations that promote pancreatic adenocarcinoma.Up-regulated miR155 reverses the epithelial-mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cellsInnovations in studying in vivo cell behavior and pharmacology in complex tissues--microvascular endothelial cells in the spotlight.Simultaneous [18F]FDG-PET/MRI: Correlation of Apparent Diffusion Coefficient (ADC) and Standardized Uptake Value (SUV) in Primary and Recurrent Cervical Cancer.Transcriptional regulation of E-cadherin and oncoprotein E7 by valproic acid in HPV positive cell lines.Gene expression profiles in HPV-immortalized human cervical cells treated with the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.Epidermal growth factor receptor kinase substrate 8 promotes the metastasis of cervical cancer via the epithelial-mesenchymal transitionGynecologic biopsy for molecular profiling: a review for the interventional radiologistDifferentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery.Epithelial-mesenchymal transition in carcinomas of the female genital tract.The importance of matrix metalloproteinase-3 in respiratory disorders.Transcriptome profiling of cancer and normal tissues from cervical squamous cancer patients by deep sequencingIdentification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma.Cdc6 expression is induced by HPV16 E6 and E7 oncogenes and represses E-cadherin expression.Alpha-linolenic acid regulates Cox2/VEGF/MAP kinase pathway and decreases the expression of HPV oncoproteins E6/E7 through restoration of p53 and Rb expression in human cervical cancer cell lines.HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition.Deregulation of the miRNAs expression in cervical cancer: human papillomavirus implications.NK cells sense tumors, course of disease and treatments: Consequences for NK-based therapies.Identification of a gene-expression signature for predicting lymph node metastasis in patients with early stage cervical carcinoma.Curcuma wenyujin extract induces apoptosis and inhibits proliferation of human cervical cancer cells in vitro and in vivo.S100A6 promotes the proliferation and migration of cervical cancer cells via the PI3K/Akt signaling pathway.Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by g-Secretase Inhibitor RO4929097.
P2860
Q24616018-98E086DB-F347-43B0-A399-90ED02DA0CEDQ30866975-3A7B579B-5577-40B9-89BF-44AEC2001894Q33306763-3C87CF8F-F46B-45A9-B973-A473810FE2BCQ33468660-37C67730-2B80-436E-9C91-9C2824A6130DQ33510812-958CBAB8-6B04-4B03-B176-227D7B488F76Q33825832-43820147-04F3-4793-A637-016B7E2168F8Q34364766-6E167C9D-FE5E-4BB6-832D-63882AE28BE3Q34533633-1A74045A-FFB8-4977-8B3D-7407D6FD5A92Q35000486-6D9EC707-ECAF-403F-9B8B-8D419C8CE7F3Q35836090-0E3CB1C1-EB34-46E4-BD13-7ECD61CCC370Q37110658-9F3020C6-A78E-4FC5-8720-5B0296F7D246Q37297154-7C88FF52-CECD-4F8C-9C06-2382074C1F04Q37297616-52F3216E-410A-4AC2-BE14-7DAFA001BE32Q37329840-8200BD94-520E-4E11-8CCA-FAAF9904C016Q37479781-1CB8EA0B-BB3E-4EB8-9BB6-389A4E9E6353Q38067434-C238E33B-6B92-48B9-AFEE-8FF5C5E1CAA0Q38215534-86A674F5-4635-4782-B9B6-1C7DFAE58AF5Q38431922-8F7ECC15-0729-4574-BEA9-88EA095833FDQ38484441-530A4BE6-52AF-4763-B2A4-37FFD4CD2CB9Q38731807-77A9CD26-A04A-471D-85F1-2B9056E59066Q38830054-4B5B2334-0122-4B45-BD32-E754C1A2607BQ39833779-C2DE258A-4FF4-4966-B5E6-C0720F950C78Q41837402-ED9DF0D3-CB15-4353-9D77-26ADA6A3E1C0Q41967990-B63BDE2B-BAB0-4B6E-B828-E50C529EFBD7Q44095909-E9C87F4D-9E5B-461A-AE88-3F123095F8ABQ53342468-2795C3B0-0675-49CF-8BF9-93C99FB67998Q54120638-7FF598A9-2D33-4F7C-B48D-5139AB33E809Q55519614-F0793A95-49AB-42D2-A648-FBFB49E2A3DD
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Molecular profiling of cervical cancer progression
@ast
Molecular profiling of cervical cancer progression
@en
Molecular profiling of cervical cancer progression
@nl
type
label
Molecular profiling of cervical cancer progression
@ast
Molecular profiling of cervical cancer progression
@en
Molecular profiling of cervical cancer progression
@nl
prefLabel
Molecular profiling of cervical cancer progression
@ast
Molecular profiling of cervical cancer progression
@en
Molecular profiling of cervical cancer progression
@nl
P2093
P2860
P3181
P356
P1476
Molecular profiling of cervical cancer progression
@en
P2093
J H Shepherd
J L Wilson
P O A Van Trappen
S A Gayther
T Bozanovic
T Hagemann
V I F Slettenaar
P2860
P2888
P3181
P356
10.1038/SJ.BJC.6603543
P407
P577
2007-01-29T00:00:00Z
P5875
P6179
1005994739